메뉴 건너뛰기




Volumn 126, Issue 3, 2016, Pages 975-991

Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO N2 [1 (5 FLUORO 2 PYRIMIDINYL)ETHYL] N4 (5 METHYL 1H PYRAZOL 3 YL) 2,4 PYRIMIDINEDIAMINE; BCR ABL PROTEIN; JANUS KINASE; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; STAT PROTEIN; THROMBOPOIETIN RECEPTOR;

EID: 84959909817     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI79196     Document Type: Article
Times cited : (44)

References (47)
  • 1
    • 0033614446 scopus 로고    scopus 로고
    • Chronic myeloid leukemia
    • Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340(17):1330-1340.
    • (1999) N Engl J Med , vol.340 , Issue.17 , pp. 1330-1340
    • Sawyers, C.L.1
  • 2
    • 74849124594 scopus 로고    scopus 로고
    • IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: An exceptionally rare observation
    • Ales M, et al. IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. Leuk Res. 2010;34(2):e58-e59.
    • (2010) Leuk Res , vol.34 , Issue.2 , pp. e58-e59
    • Ales, M.1
  • 3
    • 81555214617 scopus 로고    scopus 로고
    • Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment
    • Chu S, et al. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood. 2011;118(20):5565-5572.
    • (2011) Blood , vol.118 , Issue.20 , pp. 5565-5572
    • Chu, S.1
  • 4
    • 78049528573 scopus 로고    scopus 로고
    • Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicentre Stop Imatinib (STIM) trial
    • Mahon FX, et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol. 2010;11(11):1029-1035.
    • (2010) Lancet Oncol , vol.11 , Issue.11 , pp. 1029-1035
    • Mahon, F.X.1
  • 5
    • 77958012952 scopus 로고    scopus 로고
    • Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR
    • Ross DM, et al. Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR. Leukemia. 2010;24(10):1719-1724.
    • (2010) Leukemia , vol.24 , Issue.10 , pp. 1719-1724
    • Ross, D.M.1
  • 6
    • 84862532139 scopus 로고    scopus 로고
    • Hematopoietic stem cell heterogeneity takes center stage
    • Copley MR, Beer PA, Eaves CJ. Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell. 2012;10(6):690-697.
    • (2012) Cell Stem Cell , vol.10 , Issue.6 , pp. 690-697
    • Copley, M.R.1    Beer, P.A.2    Eaves, C.J.3
  • 7
    • 84857873445 scopus 로고    scopus 로고
    • Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs
    • Benz C, et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell. 2012;10(3):273-283.
    • (2012) Cell Stem Cell , vol.10 , Issue.3 , pp. 273-283
    • Benz, C.1
  • 8
    • 3943088431 scopus 로고    scopus 로고
    • Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
    • Jamieson CH, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 2004;351(7):657-667.
    • (2004) N Engl J Med , vol.351 , Issue.7 , pp. 657-667
    • Jamieson, C.H.1
  • 9
    • 84859832491 scopus 로고    scopus 로고
    • Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia
    • Zhang B, et al. Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell. 2012;21(4):577-592.
    • (2012) Cancer Cell , vol.21 , Issue.4 , pp. 577-592
    • Zhang, B.1
  • 10
    • 19944426030 scopus 로고    scopus 로고
    • Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
    • Koschmieder S, et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood. 2005;105(1):324-334.
    • (2005) Blood , vol.105 , Issue.1 , pp. 324-334
    • Koschmieder, S.1
  • 11
    • 84874578109 scopus 로고    scopus 로고
    • Spatial distribution of potentially bioavailable metals in surface soils of a contaminated sports ground in Galway, Ireland
    • Dao L, Morrison L, Kiely G, Zhang C. Spatial distribution of potentially bioavailable metals in surface soils of a contaminated sports ground in Galway, Ireland. Environ Geochem Health. 2013;35(2):227-238.
    • (2013) Environ Geochem Health , vol.35 , Issue.2 , pp. 227-238
    • Dao, L.1    Morrison, L.2    Kiely, G.3    Zhang, C.4
  • 12
    • 84874745627 scopus 로고    scopus 로고
    • Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptorpositive breast cancer: ATLAS, a randomised trial
    • Davies C, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptorpositive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-816.
    • (2013) Lancet , vol.381 , Issue.9869 , pp. 805-816
    • Davies, C.1
  • 13
    • 36748999351 scopus 로고    scopus 로고
    • Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche
    • Yoshihara H, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2007;1(6):685-697.
    • (2007) Cell Stem Cell , vol.1 , Issue.6 , pp. 685-697
    • Yoshihara, H.1
  • 14
    • 36749001043 scopus 로고    scopus 로고
    • Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells
    • Qian H, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007;1(6):671-684.
    • (2007) Cell Stem Cell , vol.1 , Issue.6 , pp. 671-684
    • Qian, H.1
  • 15
    • 48749084130 scopus 로고    scopus 로고
    • Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2
    • Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest. 2008;118(8):2832-2844.
    • (2008) J Clin Invest , vol.118 , Issue.8 , pp. 2832-2844
    • Bersenev, A.1    Wu, C.2    Balcerek, J.3    Tong, W.4
  • 16
    • 0032126638 scopus 로고    scopus 로고
    • Role of c-mpl in early hematopoiesis
    • Solar GP, et al. Role of c-mpl in early hematopoiesis. Blood. 1998;92(1):4-10.
    • (1998) Blood , vol.92 , Issue.1 , pp. 4-10
    • Solar, G.P.1
  • 17
    • 84942036511 scopus 로고    scopus 로고
    • Erosion of the chronic myeloid leukaemia stem cell pool by PPAR agonists
    • Prost S, et al. Erosion of the chronic myeloid leukaemia stem cell pool by PPAR? agonists. Nature. 2015;525(7569):380-383.
    • (2015) Nature , vol.525 , Issue.7569 , pp. 380-383
    • Prost, S.1
  • 18
    • 84889568419 scopus 로고    scopus 로고
    • SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors
    • Oguro H, Ding L, Morrison SJ. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell. 2013;13(1):102-116.
    • (2013) Cell Stem Cell , vol.13 , Issue.1 , pp. 102-116
    • Oguro, H.1    Ding, L.2    Morrison, S.J.3
  • 19
    • 84885634008 scopus 로고    scopus 로고
    • Platelet-biased stem cells reside at the apex of the haematopoietic stemcell hierarchy
    • Sanjuan-Pla A, et al. Platelet-biased stem cells reside at the apex of the haematopoietic stemcell hierarchy. Nature. 2013;502(7470):232-236.
    • (2013) Nature , vol.502 , Issue.7470 , pp. 232-236
    • Sanjuan-Pla, A.1
  • 20
    • 84880790360 scopus 로고    scopus 로고
    • CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age
    • Gekas C, Graf T. CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. Blood. 2013;121(22):4463-4472.
    • (2013) Blood , vol.121 , Issue.22 , pp. 4463-4472
    • Gekas, C.1    Graf, T.2
  • 21
    • 0033694302 scopus 로고    scopus 로고
    • Stem cell repopulation efficiency but not pool size is governed by p27(kip1)
    • Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med. 2000;6(11):1235-1240.
    • (2000) Nat Med , vol.6 , Issue.11 , pp. 1235-1240
    • Cheng, T.1    Rodrigues, N.2    Dombkowski, D.3    Stier, S.4    Scadden, D.T.5
  • 22
    • 79953116751 scopus 로고    scopus 로고
    • Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells
    • Fatrai S, Wierenga AT, Daenen SM, Vellenga E, Schuringa JJ. Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells. Blood. 2011;117(12):3320-3330.
    • (2011) Blood , vol.117 , Issue.12 , pp. 3320-3330
    • Fatrai, S.1    Wierenga, A.T.2    Daenen, S.M.3    Vellenga, E.4    Schuringa, J.J.5
  • 23
    • 0036330339 scopus 로고    scopus 로고
    • Thrombopoietin expands hematopoietic stem cells after transplantation
    • Fox N, Priestley G, Papayannopoulou T, Kaushansky K. Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002;110(3):389-394.
    • (2002) J Clin Invest , vol.110 , Issue.3 , pp. 389-394
    • Fox, N.1    Priestley, G.2    Papayannopoulou, T.3    Kaushansky, K.4
  • 24
    • 0030905059 scopus 로고    scopus 로고
    • Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand
    • Ohmizono Y, et al. Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand. Leukemia. 1997;11(4):524-530.
    • (1997) Leukemia , vol.11 , Issue.4 , pp. 524-530
    • Ohmizono, Y.1
  • 25
    • 0029819701 scopus 로고    scopus 로고
    • Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin-primitive progenitor cells
    • Young JC, Bruno E, Luens KM, Wu S, Backer M, Murray LJ. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin-primitive progenitor cells. Blood. 1996;88(5):1619-1631.
    • (1996) Blood , vol.88 , Issue.5 , pp. 1619-1631
    • Young, J.C.1    Bruno, E.2    Luens, K.M.3    Wu, S.4    Backer, M.5    Murray, L.J.6
  • 26
    • 80052289298 scopus 로고    scopus 로고
    • P57 is required for quiescence and maintenance of adult hematopoietic stem cells
    • Matsumoto A, et al. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell. 2011;9(3):262-271.
    • (2011) Cell Stem Cell , vol.9 , Issue.3 , pp. 262-271
    • Matsumoto, A.1
  • 27
    • 84857143671 scopus 로고    scopus 로고
    • BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
    • Hantschel O, et al. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol. 2012;8(3):285-293.
    • (2012) Nat Chem Biol , vol.8 , Issue.3 , pp. 285-293
    • Hantschel, O.1
  • 28
    • 84887392984 scopus 로고    scopus 로고
    • JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
    • Warsch W, Walz C, Sexl V. JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia. Blood. 2013;122(13):2167-2175.
    • (2013) Blood , vol.122 , Issue.13 , pp. 2167-2175
    • Warsch, W.1    Walz, C.2    Sexl, V.3
  • 29
    • 0037630266 scopus 로고    scopus 로고
    • Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs
    • Dahlen DD, Broudy VC, Drachman JG. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs. Blood. 2003;102(1):102-108.
    • (2003) Blood , vol.102 , Issue.1 , pp. 102-108
    • Dahlen, D.D.1    Broudy, V.C.2    Drachman, J.G.3
  • 30
    • 54149085320 scopus 로고    scopus 로고
    • JAK2 and MPL mutations in myeloproliferative neoplasms: Discovery and science
    • Kilpivaara O, Levine RL. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science. Leukemia. 2008;22(10):1813-1817.
    • (2008) Leukemia , vol.22 , Issue.10 , pp. 1813-1817
    • Kilpivaara, O.1    Levine, R.L.2
  • 31
    • 75649149337 scopus 로고    scopus 로고
    • Modeling the functional heterogeneity of leukemia stem cells: Role of STAT5 in leukemia stem cell self-renewal
    • Heuser M, et al. Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal. Blood. 2009;114(19):3983-3993.
    • (2009) Blood , vol.114 , Issue.19 , pp. 3983-3993
    • Heuser, M.1
  • 32
    • 84903190077 scopus 로고    scopus 로고
    • Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells
    • Cook AM, et al. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Blood. 2014;123(18):2826-2837.
    • (2014) Blood , vol.123 , Issue.18 , pp. 2826-2837
    • Cook, A.M.1
  • 33
    • 84864484317 scopus 로고    scopus 로고
    • Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling
    • Pulikkan JA, et al. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood. 2012;120(4):868-879.
    • (2012) Blood , vol.120 , Issue.4 , pp. 868-879
    • Pulikkan, J.A.1
  • 34
    • 84864448458 scopus 로고    scopus 로고
    • The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO
    • Chou FS, et al. The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO. Blood. 2012;120(4):709-719.
    • (2012) Blood , vol.120 , Issue.4 , pp. 709-719
    • Chou, F.S.1
  • 35
    • 84872047504 scopus 로고    scopus 로고
    • Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage
    • de Laval B, et al. Thrombopoietin-increased DNA-PK-dependent DNA repair limits hematopoietic stem and progenitor cell mutagenesis in response to DNA damage. Cell Stem Cell. 2013;12(1):37-48.
    • (2013) Cell Stem Cell , vol.12 , Issue.1 , pp. 37-48
    • De Laval, B.1
  • 36
    • 84879342780 scopus 로고    scopus 로고
    • Small-molecule inhibitors in myeloproliferative neoplasms: Are we aiming for the right targets?
    • Constantinescu SN, Vainchenker W. Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets? Hematology Am Soc Hematol Educ Program. 2012;2012:553-560.
    • (2012) Hematology Am Soc Hematol Educ Program , vol.2012 , pp. 553-560
    • Constantinescu, S.N.1    Vainchenker, W.2
  • 37
    • 84907368130 scopus 로고    scopus 로고
    • JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD34+ cells in vitro in vivo
    • Gallipoli P, et al. JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD34+ cells in vitro in vivo. Blood. 2014;124(9):1492-1501.
    • (2014) Blood , vol.124 , Issue.9 , pp. 1492-1501
    • Gallipoli, P.1
  • 38
    • 0028946866 scopus 로고
    • Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients
    • Radich JP, et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood. 1995;85(9):2632-2638.
    • (1995) Blood , vol.85 , Issue.9 , pp. 2632-2638
    • Radich, J.P.1
  • 39
    • 0036137923 scopus 로고    scopus 로고
    • Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa
    • Mahon FX, et al. Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa. J Clin Oncol. 2002;20(1):214-220.
    • (2002) J Clin Oncol , vol.20 , Issue.1 , pp. 214-220
    • Mahon, F.X.1
  • 40
    • 77957196195 scopus 로고    scopus 로고
    • Properties of CD34+ CML stem/ progenitor cells that correlate with different clinical responses to imatinib mesylate
    • Jiang X, et al. Properties of CD34+ CML stem/ progenitor cells that correlate with different clinical responses to imatinib mesylate. Blood. 2010;116(12):2112-2121.
    • (2010) Blood , vol.116 , Issue.12 , pp. 2112-2121
    • Jiang, X.1
  • 41
    • 84896729095 scopus 로고    scopus 로고
    • Maintaining low BCR-ABL signaling output to restrict CML progression and enable persistence
    • Burchert A. Maintaining low BCR-ABL signaling output to restrict CML progression and enable persistence. Curr Hematol Malig Rep. 2014;9(1):9-16.
    • (2014) Curr Hematol Malig Rep , vol.9 , Issue.1 , pp. 9-16
    • Burchert, A.1
  • 42
    • 0032211172 scopus 로고    scopus 로고
    • The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease
    • Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92(9):3362-3367.
    • (1998) Blood , vol.92 , Issue.9 , pp. 3362-3367
    • Bose, S.1    Deininger, M.2    Gora-Tybor, J.3    Goldman, J.M.4    Melo, J.V.5
  • 43
    • 77952422869 scopus 로고    scopus 로고
    • Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP
    • Koehrer S, Keating MJ, Wierda WG. Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP. Leukemia. 2010;24(5):1096-1098.
    • (2010) Leukemia , vol.24 , Issue.5 , pp. 1096-1098
    • Koehrer, S.1    Keating, M.J.2    Wierda, W.G.3
  • 44
    • 84863524725 scopus 로고    scopus 로고
    • Eltrombopag and improved hematopoiesis in refractory aplastic anemia
    • Olnes MJ, et al. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012;367(1):11-19.
    • (2012) N Engl J Med , vol.367 , Issue.1 , pp. 11-19
    • Olnes, M.J.1
  • 45
    • 84897513351 scopus 로고    scopus 로고
    • Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug
    • Desmond R, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123(12):1818-1825.
    • (2014) Blood , vol.123 , Issue.12 , pp. 1818-1825
    • Desmond, R.1
  • 46
    • 0029915482 scopus 로고    scopus 로고
    • High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations
    • Jordan CT, Yamasaki G, Minamoto D. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol. 1996;24(11):1347-1355.
    • (1996) Exp Hematol , vol.24 , Issue.11 , pp. 1347-1355
    • Jordan, C.T.1    Yamasaki, G.2    Minamoto, D.3
  • 47
    • 79751528964 scopus 로고    scopus 로고
    • Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells
    • Modi H,Li L, Chu S, Rossi J, Yee JK, Bhatia R. Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells. Leukemia. 2011;25(2):305-312.
    • (2011) Leukemia , vol.25 , Issue.2 , pp. 305-312
    • Modi Hli, L.1    Chu, S.2    Rossi, J.3    Yee, J.K.4    Bhatia, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.